---
layout: splash
title: SK바이오사이언스 (302440)
excerpt: SK바이오사이언스의 최근 공시, 수익률, 주요 재무/기술 지표
header:
  overlay_color: "#333"
  show_overlay_excerpt: false
categories:
- KOSPI
- P:의약품
keywords: SK바이오사이언스, 302440
---

| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 61,200 | <span style="color: tomato">1.2<small>%</small></span> | P:의약품 | 38.4 | 2.7 | - |

<!-- more -->


> **기업 개요**<a id="company"></a>

| <span style="white-space:nowrap;">**섹터**</span> | P:의약품 / 기초 의약물질 및 생물학적 제제 제조업 |
| <span style="white-space:nowrap;">**산업**</span> | 백신 제품 및 제제 |
| <span style="white-space:nowrap;">**상장**</span> | KOSPI / 2021년 3월 18일 상장 / 12월 결산 |
| <span style="white-space:nowrap;">**대표자**</span> | 안재용 |
| <span style="white-space:nowrap;">**홈페이지**</span> | [http://www.skbioscience.com](http://www.skbioscience.com){:target="_blank"} |


> **최근 7일 DART 신규 공시**<a id="dart"></a>

| **일자** |      | **보고서명** |
| :------- | :--- | :----------- |
| 03&#x2011;15 | | [사업보고서 (2023.12)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240315000914){:target="_blank"} |
|  | | [감사보고서제출              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240315800650){:target="_blank"} |
| 03&#x2011;13 | | [[기재정정]의결권대리행사권유참고서류](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240313001690){:target="_blank"} |
|  | | [[기재정정]주주총회소집공고](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240313001667){:target="_blank"} |


> **주가 흐름**<a id="price"></a>

![302440](/stock/images/302440.png){: .align-center}


> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 61,200 | <span style="color: tomato">1.2<small>%</small></span> | <span style="color: cornflowerblue">-1.0<small>%</small></span> | <span style="color: cornflowerblue">-5.6<small>%</small></span> | <span style="color: cornflowerblue">-11.4<small>%</small></span> | <span style="color: cornflowerblue">-15.8<small>%</small></span> |
| **1년** | **편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: cornflowerblue">-14.5<small>%</small></span> | 39.2<small>%</small> | -0.37 | -31.9<small>%</small> | -15.0<small>%</small> | 0.5 |


> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| P:의약품 | 38.4 | 2.7 | - | - |



{% include /commons/ads/adsense.html %}

> **세부 재무/투자 정보 제공 사이트**

| [네이버](https://m.stock.naver.com/domestic/stock/302440/finance/summary){:target="_blank"}<sup><small>모바일</small></sup> | [네이버](https://finance.naver.com/item/coinfo.naver?code=302440){:target="_blank"} | [FnGuide](https://comp.fnguide.com/SVO2/ASP/SVD_Invest.asp?gicode=A302440&MenuYn=Y){:target="_blank"} |
| :---: | :---: | :---: |
| [와이즈리포트](https://comp.wisereport.co.kr/company/c1040001.aspx?cmp_cd=302440){:target="_blank"} | [밸류라인](https://www.valueline.co.kr/finance/summary/302440){:target="_blank"} | [한국경제](https://markets.hankyung.com/stock/302440/financial-summary){:target="_blank"} |


> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![302440](/stock/images/302440_tech.png){: .align-center}

| **기술 지표** | **1년** | **편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | -14.5<small>%</small> | 39.2<small>%</small> | -0.37 | -31.9<small>%</small> | -15.0<small>%</small> |
| 적립식[^fn_tech_metric_dca] | -13.4<small>%</small> | 38.6<small>%</small> | -0.35 | -31.7<small>%</small> | -15.2<small>%</small> |
| Sig. M[^fn_tech_metric_sigm] | -8.0<small>%</small> | 27.1<small>%</small> | -0.30 | -26.7<small>%</small> | -13.7<small>%</small> |
| SMA<small><sub>(5)</sub></small>[^fn_tech_metric_sma_i] | -8.2<small>%</small> | 31.1<small>%</small> | -0.26 | -18.9<small>%</small> | -11.7<small>%</small> |
| SMA<small><sub>(20)</sub></small>[^fn_tech_metric_sma_i] | -20.1<small>%</small> | 26.2<small>%</small> | -0.76 | -32.4<small>%</small> | -22.6<small>%</small> |
| SMA<small><sub>(60)</sub></small>[^fn_tech_metric_sma_i] | -21.8<small>%</small> | 23.4<small>%</small> | -0.93 | -27.1<small>%</small> | -20.8<small>%</small> |
| SMA<small><sub>(120)</sub></small>[^fn_tech_metric_sma_i] | -25.0<small>%</small> | 22.2<small>%</small> | -1.12 | -27.0<small>%</small> | -19.7<small>%</small> |
| SMA<small><sub>(240)</sub></small>[^fn_tech_metric_sma_i] | -6.2<small>%</small> | 7.9<small>%</small> | -0.79 | -7.8<small>%</small> | -4.4<small>%</small> |
| MACD[^fn_tech_metric_macd] | -12.1<small>%</small> | 29.4<small>%</small> | -0.41 | -27.3<small>%</small> | -17.3<small>%</small> |


> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![302440](/stock/images/302440_corr.png){: .align-center}

|       | [효성첨단소재](/298050/) | [LG이노텍](/011070/) | [SK이노베이션](/096770/) |
| :---: | :------------------------------------: | :------------------------------------: | :------------------------------------: |
|       | [명신산업](/009900/) | [에스에프에이](/056190/) | [넥슨게임즈](/225570/) |


> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![302440](/stock/images/302440_2x.png){: .align-center}


> **관련 정보**

- [P:의약품 업종 목록](/stats/sector/kospi_업종_의약품_종목/){: .btn .btn--info}

{% include commons/footnotes.md %}